A Review of: “Good Design Practices for GMP Pharmaceutical Facilities”

By Mitchell David   Keuer Tom  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 2, 2006-03 ,pp. : 263-263

Informa Healthcare

Access to resources Recommend Favorite

Widespread Hyoscine Hydrobromide Toxicity Due to Contract Manufacturer Malpractice: The Travacalm Episode

By McEwen John  

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 375-378

Adis International

Access to resources Recommend Favorite

System audit of contract research organizations in Germany

By D C.   M G.   H L.   S L.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 191-193

Adis International

Access to resources Recommend Favorite

Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manufacturer take heed

By Nicholson Susan   Peterson Janet   Yektashenas Behin  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 299-314

Informa Healthcare

Access to resources Recommend Favorite

Simultaneous spectrophotometric determination of pseudoephedrine hydrochloride and ibuprofen in a pharmaceutical preparation using ratio spectra derivative spectrophotometry and multivariate calibration techniques

By Palabiyik I.M.   Dinc E.   Onur F.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 34, Iss. 3, 2004-02 ,pp. : 473-483

Elsevier

Access to resources Recommend Favorite